Spyre Therapeutics, Inc.
SYRE
$15.18
$0.644.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.54% | 77.76% | 103.45% | 81.00% | 1,159.53% |
| Total Receivables | -- | -- | 942.94% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -41.19% | 139.27% | 135.57% | 237.99% | -52.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 16.93% | 78.16% | 104.46% | 81.64% | 998.08% |
|
|
|||||
| Total Current Assets | 16.93% | 78.16% | 104.46% | 81.64% | 998.08% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -96.96% | -96.98% | -99.24% | -75.06% | -76.30% |
| Total Assets | 16.85% | 77.99% | 103.16% | 79.06% | 829.60% |
|
|
|||||
| Total Accounts Payable | 18.77% | -25.67% | 207.81% | 13.21% | 50.63% |
| Total Accrued Expenses | -42.73% | -6.49% | -5.59% | -66.54% | 295.50% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1,665.60% | 1,288.92% | 36.31% | -95.17% | 345.78% |
| Total Other Current Liabilities | 1,665.60% | 1,288.92% | 36.31% | -95.17% | 345.78% |
| Total Current Liabilities | 65.07% | 69.05% | 28.23% | -90.47% | 238.83% |
|
|
|||||
| Total Current Liabilities | 65.07% | 69.05% | 28.23% | -90.47% | 238.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -94.36% | -70.91% | 74.77% | 85.37% | 12,395.30% |
| Total Liabilities | -74.01% | -42.55% | 42.92% | -75.68% | 1,683.59% |
|
|
|||||
| Common Stock & APIC | 73.11% | 74.82% | 138.23% | 134.98% | 62.44% |
| Retained Earnings | -25.85% | -27.21% | -30.65% | -28.13% | -82.02% |
| Treasury Stock & Other | 287.88% | -40.40% | 1,203.79% | -5,127.27% | -5,950.00% |
| Total Common Equity | 1,100.64% | 39,834.80% | 169.91% | 205.40% | -197.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -15.74% | -15.74% | -59.75% | -21.03% | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -15.74% | -15.74% | -59.75% | -21.03% | -- |
|
|
|||||
| Total Common Equity | 1,100.64% | 39,834.80% | 169.91% | 205.40% | -197.05% |
| Total Preferred Equity | -15.74% | -15.74% | -59.75% | -21.03% | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 216.95% | 181.39% | 131.04% | 3,826.71% | 352.48% |
|
|
|||||